C09971187 / invoice 10000
Species:CANINE
Breed:Cocker Spaniel
Age (years):8
Diagnosis or signs:Chemotherapy
Consult notes
02/03/2026 ** ADMISSION PROCEDURE: chemotherapy NURSE: LM HISTORY: Going well, no concerns MEDICATIONS: Trazodone this am PLAN: Admit for chemo today -------------------------------------------------- CHEMOTHERAPY WEEK: 11 NURSE: LM/OB TPR: HR: 120bpm RR: 24bpm Temp: 38C Abdo NSF, other than palpable faeces/enlarged lymph node L AG around 4cm Weight - 15kg BSA - 0.614 m2 LABORATORY: Haematology - Neutrophils 4.29 (2.95 - 11.64 x10^9/L) N Lymphocytes 0.77 (1.05 - 5.10 x10^9/L) L Platelets 206 (148 - 484 x10^9/L) N Blood Smear - CREA: Creatinine 41 (44 - 159 µmol/L) N ALT: ALT 72 (10 - 125 U/L) N TREATMENT: Prevomax 1.5mL SC Melphelan 2mg x 5 tablets given PO in RC GI low fat - ate well BSA = 0.61, dose = 17mg/m2 PLAN: RV in 1 week for CBC RV in 2 weeks for repeat Melphelan Use antiemetics as required
Animal clinical history (3 most recent)
2026-03-02T00:00:00Z 08:43:48
** ADMISSION PROCEDURE: chemotherapy NURSE: LM HISTORY: Going well, no concerns MEDICATIONS: Trazodone this am PLAN: Admit for chemo today -------------------------------------------------- CHEMOTHERAPY WEEK: 11 NURSE: LM/OB TPR: HR: 120bpm RR: 24bpm Temp: 38C Abdo NSF, other than palpable faeces/enlarged lymph node L AG around 4cm Weight - 15kg BSA - 0.614 m2 LABORATORY: Haematology - Neutrophils 4.29 (2.95 - 11.64 x10^9/L) N Lymphocytes 0.77 (1.05 - 5.10 x10^9/L) L Platelets 206 (148 - 484 x10^9/L) N Blood Smear - CREA: Creatinine 41 (44 - 159 µmol/L) N ALT: ALT 72 (10 - 125 U/L) N TREATMENT: Prevomax 1.5mL SC Melphelan 2mg x 5 tablets given PO in RC GI low fat - ate well BSA = 0.61, dose = 17mg/m2 PLAN: RV in 1 week for CBC RV in 2 weeks for repeat Melphelan Use antiemetics as required
Previous claim history (12)
| Date | Claim # | Diagnosis |
|---|---|---|
| 2026-02-26 | C09959611 | ADENOCARCINOMA |
| 2026-02-10 | C09881438 | ADENOCARCINOMA |
| 2026-02-02 | C09837094 | ADENOCARCINOMA |
| 2026-01-27 | C09810235 | ADENOCARCINOMA |
| 2026-01-19 | C09777582 | ADENOCARCINOMA |
| 2026-01-12 | C09743852 | ADENOCARCINOMA |
| 2026-01-04 | C09706217 | ADENOCARCINOMA |
| 2025-12-30 | C09691530 | PRESCRIPTION DIETS |
| 2025-12-23 | C09691530 | ADENOCARCINOMA |
| 2025-12-16 | C09653097 | ADENOCARCINOMA |
| 2025-12-15 | C09626917 | ADENOCARCINOMA |
| 2025-12-11 | C09626948 | ADENOCARCINOMA |
Line items(lines with upstream diagnosis are skipped by the model)
| Line | tstarc | Amount | Date | Upstream diagnosis |
|---|---|---|---|---|
| 10000 | tstarc_diagnostic_test_-_haematology | 71.64 | 2026-03-02 | — |
| 20000 | tstarc_hospitalisation | 47.00 | 2026-03-02 | — |
| 30000 | tstarc_consultation | 135.00 | 2026-03-02 | — |
| 40000 | tstarc_diagnostic_test_-_creatinine | 56.42 | 2026-03-02 | — |
| 50000 | tstarc_diagnostic_test_-_biochemistry | 56.42 | 2026-03-02 | — |
| 60000 | tstarc_anti-nausea_medication | 51.01 | 2026-03-02 | — |
UPM+
- DG00089ADENOCARCINOMADSTP_adenocarcinoma
Variant (sleepy_king)
ADENOCARCINOMA
DSTP_adenocarcinoma
Conf: 0.990
Threshold: 0.90
Above: ✓
Correct?